Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer

Detalles Bibliográficos
Autores principales: Mao, C, Liao, R-Y, Chen, Q
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833261/
https://www.ncbi.nlm.nih.gov/pubmed/20160728
http://dx.doi.org/10.1038/sj.bjc.6605575
_version_ 1782178375842922496
author Mao, C
Liao, R-Y
Chen, Q
author_facet Mao, C
Liao, R-Y
Chen, Q
author_sort Mao, C
collection PubMed
description
format Text
id pubmed-2833261
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-28332612011-03-02 Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer Mao, C Liao, R-Y Chen, Q Br J Cancer Letter to the Editor Nature Publishing Group 2010-03-02 2010-02-16 /pmc/articles/PMC2833261/ /pubmed/20160728 http://dx.doi.org/10.1038/sj.bjc.6605575 Text en Copyright © 2010 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Mao, C
Liao, R-Y
Chen, Q
Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
title Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
title_full Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
title_fullStr Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
title_full_unstemmed Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
title_short Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
title_sort loss of pten expression predicts resistance to egfr-targeted monoclonal antibodies in patients with metastatic colorectal cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833261/
https://www.ncbi.nlm.nih.gov/pubmed/20160728
http://dx.doi.org/10.1038/sj.bjc.6605575
work_keys_str_mv AT maoc lossofptenexpressionpredictsresistancetoegfrtargetedmonoclonalantibodiesinpatientswithmetastaticcolorectalcancer
AT liaory lossofptenexpressionpredictsresistancetoegfrtargetedmonoclonalantibodiesinpatientswithmetastaticcolorectalcancer
AT chenq lossofptenexpressionpredictsresistancetoegfrtargetedmonoclonalantibodiesinpatientswithmetastaticcolorectalcancer

Ejemplares similares